Indivior Pharmaceuticals, Inc. Common Stock (INDV) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for INDV. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 18,709,432 | $768M | INCREASED |
| State Street | 4,992,071 | $205M | INCREASED |
| Assenagon Asset Management | 1,540,928 | $63M | NEW |
| Lsv Asset Management | 1,024,724 | $42M | INCREASED |
| Principal Financial Group | 772,174 | $32M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Woodrow D Anderson (Chief Accounting Officer) | BUY | 1,500 | $54K | 2026-08-05 |
| Christian Heidbreder (Chief Scientific Officer) | SELL | 18,586 | $765K | 2026-07-10 |
| Joseph Ciaffoni (Chief Executive Officer) | SELL | 612,549 | $23M | 2026-06-22 |
| Joseph Ciaffoni (Chief Executive Officer) | EXERCISE | 1,266,903 | 2026-06-22 | |
| Christian Heidbreder (Chief Scientific Officer) | SELL | 18,586 | $707K | 2026-06-11 |
Full institutional holdings, insider history, and congressional trades for Indivior Pharmaceuticals, Inc. Common Stock on SentiSense.